Posttransplant lymphoproliferative disorder after liver and kidney transplant

Experimental and Clinical Transplantation

Volumn 12, Issue SUPPL. 1, 2014, Pages 142-148

  Özkan, Eylem Akar ^a   Handan Ozdemir B ^a   Ebru Deniz, E ^a   Zeyneb Tunca, M ^a   Haberal, Mehmet ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Epstein Barr virus; Kidney transplant recipient; Liver transplant; Posttransplant lymphoproliferative disorder

Indexed keywords

ANTIMETABOLITE; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN; METHYLPREDNISOLONE; SMALL INTERFERING RNA; TACROLIMUS; THYMOCYTE ANTIBODY; IMMUNOSUPPRESSIVE AGENT; VIRUS RNA;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; B CELL MONOMORPHIC POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER; CAUSE OF DEATH; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG PULSE THERAPY; EPSTEIN BARR VIRUS; ETHNIC GROUP; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MALE; RISK FACTOR; SURVIVAL TIME; T CELL MONOMORPHIC POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER; TREATMENT INDICATION; TURKISH; ADOLESCENT; EPSTEIN-BARR VIRUS INFECTIONS; GENETICS; INFANT; ISOLATION AND PURIFICATION; LYMPHOPROLIFERATIVE DISORDERS; MIDDLE AGED; MORTALITY; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SURVIVAL; TIME; TREATMENT OUTCOME; TURKEY; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; INFANT; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; RNA, VIRAL; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; TURKEY; YOUNG ADULT;

EID: 84897397863     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: 10.6002/ect.25Liver.P30     Document Type: Article

References (14)

1. Penn I, Hammond W, Brettschneider L, Starzl TE. Malignant lymphomas in transplantation patients. Transplant Proc. 1969;1(1):106-112.
2. Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (WHO Classification of Tumours, Volume 2). 4th ed. Lyon, France: International Agency for Research on Cancer; 2008.
3. Jaffe ES, Harris NL, Vardiman JW, Campo E, Arber DA, ed. Hematopathology. St Louis, MO: Sounders Elsevier; 2011.
4. Parker A, Bowles K, Bradley JA, et al. Diagnosis of post-transplant lymphoproliferative disorder in solid-organ transplant recipients-BCSH and BTS Guidelines. Br J Haematol. 2010;149(5):675-692.
5. Hussein K, Tiede C, Maecker-Kolhoff B, Kreipe H. Posttransplant lymphoproliferative disorder in pediatric patients. Pathobiology. 2013;80(6):289-296.
6. Clarke CA, Morton LM, Lynch C, et al. Risk of lymphoma subtypes after solid-organ transplantation in the United States. Br J Cancer. 2013;109(1):280-288.
7. Lo RC, Chan SC, Chan KL, Chiang AK, Lo CM, Ng IO. Post-transplant lymphoproliferative disorders in liver transplant recipients: a clinicopathological study. J Clin Pathol. 2013;66(5):392-398.
8. Mynarek M, Schober T, Behrends U, Maecker-Kolhoff B. Posttransplant lymphoproliferative disease after pediatric solid-organ transplantation. Clin Dev Immunol. 2013;2013:814973. doi: 10.1155/2013/814973. Epub 2013 Sep 24.
9. Chen DB, Song QJ, Chen YX, Chen YH, Shen DH. Clinicopathologic spectrum and Epstein-Barr virus status of post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation. Int J Hematol. 2013;97(1):117-124.
10. Evens AM, David KA, Helenowski I, et al. Multicenter analysis of 80 solid-organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era. J Clin Oncol. 2010;28(6):1038-1046.
11. Dierickx D, Tousseyn T, Sagaert X, et al. Single-center analysis of biopsy-confirmed posttransplant lymphoproliferative disorder: incidence, clinicopathological characteristics and prognostic factors. Leuk Lymphoma. 2013;54(11):2433-2440.
12. Khedmat H, Taheri S. Hepatic lymphomas post renal transplantation may signify worse disease behavior: analysis of data from 26 international studies. Arab J Nephrol Transplant. 2011;4(3):109-116.
13. Quinlan SC, Morton LM, Pfeiffer RM, et al. Increased risk for lymphoid and myeloid neoplasms in elderly solid-organ transplant recipients. Cancer Epidemiol Biomarkers Prev. 2010;19(5);1229-1237.
14. Vajdic CM, van Leeuwen MT, Turner JJ, et al. No excess risk of follicular lymphoma in kidney transplant and HIV-related immunodeficiency. Int J Cancer. 2010;127(11):2732-2735.